US4327082A
(en)
*
|
1979-07-12 |
1982-04-27 |
Adcock-Ingram Laboratories Limited |
Mastitis vaccination
|
US4425330A
(en)
|
1981-05-20 |
1984-01-10 |
Cornell Research Foundation, Inc. |
Bovine mastitis vaccine and method for detecting efficacy thereof
|
US4762712A
(en)
*
|
1983-08-31 |
1988-08-09 |
Stolle Research & Development Corporation |
Anti-mastitis polyvalent vaccine, method of administration and method for production thereof
|
DE3345864A1
(de)
*
|
1983-12-19 |
1985-06-27 |
Egbert Frh. von 8000 München Malsen-Ponickau |
Impfstoff und verfahren zu seiner herstellung
|
JPS62165286U
(fr)
*
|
1986-04-07 |
1987-10-20 |
|
|
FR2619122B1
(fr)
*
|
1987-08-03 |
1990-03-09 |
Pasteur Institut |
Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
|
US5034515A
(en)
*
|
1987-09-22 |
1991-07-23 |
Wisconsin Alumni Research Foundation |
Staphylococcal fibronectin receptor, monoclonal antibodies thereto and methods of use
|
US5055455A
(en)
*
|
1988-09-28 |
1991-10-08 |
Brigham And Women's Hospital |
Capsular polysaccharide adhesin antigen, preparation, purification and use
|
US5571511A
(en)
*
|
1990-10-22 |
1996-11-05 |
The U.S. Government |
Broadly reactive opsonic antibodies that react with common staphylococcal antigens
|
US20080139789A1
(en)
*
|
1990-10-22 |
2008-06-12 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection
|
US6632432B1
(en)
|
1990-10-22 |
2003-10-14 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Directed human immune globulin for the prevention and treatment of staphylococcal infections
|
US7279162B1
(en)
*
|
1990-10-22 |
2007-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
|
ES2198405T3
(es)
*
|
1991-11-22 |
2004-02-01 |
Nabi Biopharmaceuticals |
Antigenos de superficie de tipo i asociados a staphylococcus epidermis.
|
US5980908A
(en)
*
|
1991-12-05 |
1999-11-09 |
Alfa Laval Ab |
Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
|
AU673508B2
(en)
*
|
1992-02-25 |
1996-11-14 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Directed human immune globulin for the prevention and treatment of staphylococcal infections
|
US6610293B1
(en)
|
1997-06-16 |
2003-08-26 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
|
US7250494B2
(en)
*
|
1998-06-15 |
2007-07-31 |
Biosynexus Incorporated |
Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
|
US7252828B2
(en)
|
1998-07-15 |
2007-08-07 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
US6984381B2
(en)
|
2002-07-05 |
2006-01-10 |
The United States Of America As Represented By The Secretary Of Agriculture |
Vaccine for the prevention of bacterial infection of the bovine mammary gland
|
EP1583517B1
(fr)
*
|
2002-11-12 |
2019-06-12 |
The Brigham And Women's Hospital, Inc. |
Methodes et produits de traitement des infections staphylococciques
|
EP1565478B1
(fr)
|
2002-11-12 |
2017-08-02 |
The Brigham And Women's Hospital, Inc. |
Vaccin a base de polysaccharide destine a combattre les infections aux staphylocoques
|
DK1745075T3
(da)
|
2004-04-21 |
2013-06-24 |
Brigham & Womens Hospital |
Poly-n-acetylglucosamin (pnag/dpnag)-bindende peptider og fremgangsmåder til anvendelse deraf
|
EP1804833A2
(fr)
|
2004-09-22 |
2007-07-11 |
GlaxoSmithKline Biologicals SA |
Compositions immunogenes de staphylocoques
|
EP2476433A1
(fr)
|
2006-03-30 |
2012-07-18 |
GlaxoSmithKline Biologicals S.A. |
Composition immunogène
|
DK2315747T3
(en)
|
2008-07-21 |
2018-02-26 |
Brigham & Womens Hospital Inc |
Methods and Compositions of Synthetic Beta-1.6 Glucosamine Oligosaccharides
|
CN102333540B
(zh)
|
2008-10-06 |
2015-04-22 |
芝加哥大学 |
与细菌eap、emp和/或adsa蛋白相关的组合物和方法
|
TW201043267A
(en)
*
|
2009-03-19 |
2010-12-16 |
Intervet Int Bv |
In situ constituting a vaccine for administration to a predetermined herd of animals
|
GB0913680D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
JP2013506651A
(ja)
|
2009-09-30 |
2013-02-28 |
ノバルティス アーゲー |
Staphylococcus.aureus5型および8型莢膜多糖の結合体
|
PL2493498T3
(pl)
|
2009-10-30 |
2017-08-31 |
Glaxosmithkline Biologicals Sa |
Oczyszczanie sacharydów otoczkowych staphylococcus aureus typu 5 i typu 8
|
US20130315959A1
(en)
|
2010-12-24 |
2013-11-28 |
Novartis Ag |
Compounds
|
WO2013038375A2
(fr)
|
2011-09-14 |
2013-03-21 |
Novartis Ag |
Procédés de production de glycoconjugués de saccharide-protéine
|
CN104080479B
(zh)
|
2011-11-07 |
2019-11-05 |
葛兰素史密丝克莱恩生物有限公司 |
包括spr0096和spr2021抗原的运载体分子
|
GB201121301D0
(en)
|
2011-12-12 |
2012-01-25 |
Novartis Ag |
Method
|
SG11201407440WA
(en)
|
2012-05-22 |
2014-12-30 |
Novartis Ag |
Meningococcus serogroup x conjugate
|
US11041217B2
(en)
*
|
2018-01-05 |
2021-06-22 |
Azitra Inc |
Auxotrophic strains of staphylococcus bacterium
|